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Abstract 
Discovering drugs to a disease is still a challenging task for medical researchers due to the complex 
structures of biomolecules which are responsible for disease such as AIDS, Cancer, Autism, Alzimear etc. Design 
and development of new efficient anti-drugs for the disease without any side effects are becoming mandatory in the 
recent history of human life cycle due to changes in various factors which includes food habit, environmental and 
migration in human life style. Cheminformaticds  deals with discovering drugs based in modern drug discovery 
techniques which in turn rectifies complex issues in traditional drug discovery system. Cheminformatics tools , helps 
medical chemist for better understanding of complex structures of chemical compounds. Cheminformatics is a new 
emerging interdisciplinary field which primarily aims to discover Novel Chemical Entities [NCE] which ultimately 
results in design of new molecule [chemical data]. It also plays an important role for collecting, storing and analysing 
the chemical data. This paper focuses on cheminformatics and its applications on drug discovery and modern drug 
discovery techniques which helps chemist and medical researchers for finding solution to the complex disease. 
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1. Introduction 
so referred as Chemoinformatics/Chemiinformatics /Chemical 
informat ion/Chemical informat ics has been recognised in recent years as a distinct discipline in 
computational molecu lar sciences. Cheminformat ics is also known as interface science as it combines 
Physics, Chemistry, Biology, Mathematics, Biochemistry, Statistics and in formatics [3][5][24]. 
The primary focus of cheminformatics is to analyse/simulate/modelling/manipulate chemical 
informat ion which can represented either in 2D structure or in 3D structure. Industry sectors such as, 
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agrochemicals, food and pharmaceutical are distinct areas where cheminformat ics plays significant ro le in 
the recent history of molecular sciences [5][14][15]. 
Cheminformat ics is a generic term that encompasses the design, creation, organizat ion, 
management, retrieval, analysis, dissemination, visualizat ion, and use of chemical informat ion [3].  
of the drug discovery process.  Cheminformat ics is the mixing  of information resources to transform data  
into information and informat ion into knowledge which is collectively referred  as inductive learning as 
shown in Fig.1. for the intended purpose of making better decisions faster in  the areas of drug lead 
J. Gasteiger and T. Engel perception, cheminformat ics can be 
Green coined cheminform  
 
     
 Fig. 1. Cheminformatics transformation  
 
   Cheminformat ics has mainly  dealt with small molecules, whereas bio informat ics addresses genes, 
proteins, and other larger chemical compounds (shown in Fig . 2). Chem and Bioinformatics complements 
each other for bimolecu lar process,  like  structure and function of proteins, the binding of a ligand to its 
binding site, the conversion of a substrate within its enzyme receptor, and the catalysis of a biochemical 
reaction by an enzyme. 
 
 
 
Fig. 2. The Cooperation of Bioinformatics and Cheminformatics 
 
Different tools and methods are available to represent chemical structure, database to store chemical 
data, to perform searching process, Quality Structure- Activ ity Relationship(QSAR), Quality Structure-
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Property Relationship(QSPR), to predict physical, chemical and bio logical p roperties of a 
molecule[6][5][8][13].  
1.1 NEED AND IMPORTANCE OF CHEMINFORMATICS 
Cheminformat ics plays a key ro le to maintain and access enormous amount of chemical data, 
produced by chemist (more than 45 million chemical compounds are known and the number may  increase 
in million every year,) by using a proper database. Also, the field of chemistry needs a novel technique 
for knowledge extraction from data to model complex relat ionships between the structure of the chemical 
compound and biological activity or the influence of reaction condition on chemical reactiv ity [6][16]. 
Cheminformat ics has wider range of application and  Fig. 3.  shows influence if cheminformatics in some 
specific research areas. 
 
 
Fig.  3.  Need for Cheminformatics 
 
Three major aspects of Cheminformatics are; 
i) Information Acquisition, is a process of generating and collecting data empirically 
(experimentation) or from theory (molecular simulation) 
ii) Information Management deals with storage and retrieval of information and 
iii) Information use, which includes Data Analysis, correlation, and application to problems in 
the chemical and biochemical sciences [24] 
This paper is organized as follows. Section 2 deals with significant applicat ions of 
Cheminformat ics on various research areas. Section 3 specifies different tools available for analysis, 
visualize and interpret the properties of chemical information. Section 4 rev iews the ro le of 
cheminformatics for drug discovery and Section 6 concludes the paper. 
 
2. Cheminformatics and its Applications 
Cheminformat ics is a significant application of informat ion technology to help chemists for 
investigating new problems, organize, analyse, and understand scientific data in the development of 
novel compounds, materials and processes. Primary  modules of cheminformatics are Computer-Assisted 
Synthesis Design, Structure representation and chemmetrics, shown in Fig. 4. [3][4][5][7][8][14][15]. 
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Fig. 4. Different areas focused in Cheminformatics 
 
Computer-Assisted Synthesis Design (CASD) is applied mainly where art ificial intelligence 
technique can be applied. This technique is applied in various applications which included 
pharmaceutical, food industry, textile industry and agro industry. 
Various forms of machine readable chemical representation play basic property to design chemical 
database where the chemical informat ion are stored for analysis and manipulat ion. The chemical structure 
representations can be linear, 2D or in 3D format. Some of the chemical structure representations are 
shown in Table 1. SMILES (Simplified Molecular Input Line Entry Specification) is one of the linear 
chemical notation format  which is widely used among chemist [38] for various clin ical and analysis 
purpose. Structure representation deals with Reaction Representation, Structure Descriptors, Molecular 
Modelling, Structure Searching, and Computer-Assisted Structure Elucidation (CASE) as shown in Fig.5.  
 
Table 1: Some of the Chemical Structure Representation 
 
Representation Name 
Caffine Common Name 
trimethylxanthine coffeine, theine, mateine,  Synonyms 
C8H10N4O2 Empirical formula 
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione IUPAC Name 
58-08-2 CAS Registry Number 
T56 BN DN FNVNVJ B1 F1 H1 WLN Notation 
CN1C=NC2=C1C(=O)N(C(=O)N2C)C SMILES 
1S/C8H10N4O2/c1-10-4-9-6-
5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3 
Inchl 
 
Markush Structure 
Connection Table 
[OH]c1cccc1 Fragment Code 
0000100110100111 Fingerprint 
5244987098423150 Hash Code 
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Reaction Representation helps to understand the basic chemical models, quantify chemical react ivity 
and extract knowledge from the reaction informat ion [23]. Molecu lar modelling is a method includes a 
variety of computational schemes which are aimed at stimulat ing molecular structures, their properties 
in-  behaviour [8]. 
 
 
Fig. 5.  CASD and Structure representation  
 
Structure Search ing involves in  determination  of features like bond orders, rings and aromaticity. It 
includes searching the whole structure, substructure, structure similarity and diversity. CASE builds on 
informat ion obtained from various spectroscopic methods like IR, NMR, MS, et c. Structure Descriptor 
used to identify the physical, chemical and biological properties of chemical compound and relationship 
between two structures. The descriptors fall into four classes such as, i) Topological, ii) Geometrical, iii) 
Electronic and iv) Hybrid or 3D Descriptors [14][23]. 
 
 
 
 Fig. 6. Structure Representation and Chemmetrics 
 
 Chemmetrics is used for quantitative analyse of the chemical data by using mathematical and 
statistical methods [45]. It also deals with property prediction of chemical information (refer Fig . 6.). 
2.1 APPLICATIONS OF CHEMINFORMATICS 
The range of applications of cheminformatics is rich indeed; any field of chemistry can profit from 
its methods. The following lists different areas of chemistry and indicates some typical applicat ions of 
cheminformatics.  
a) Storing data generated through experiments or from molecular simulat ion Retrieval of chemical 
Structures from chemical database (Software libraries).   
b) Prediction of physical, chemical and biological properties of chemical compounds. 
c) Elucidation of the structure of a compound based on spectroscopic data. 
d) Structure, Substructure, Similarity and diversity searching from chemical database [14][15]. 
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e) High Throughput Screening (HTS) is the integration of technologies (laborat ory automat ion, 
assay technology, micro plate based instrumentation, etc.) to quickly screen chemical 
compounds in search of a desired activity [19]. 
f) Docking - Interaction between two macromolecules [17][18]. 
g) Drug Discovery [11][12][15][24]. 
h) Molecular Science, Materials Science, Food Science (nutraceuticals), Atmospheric chemistry, 
Polymer chemistry, Textile Industry, Combinatorial organic synthesis (COS) [4]. 
3. Tools Used for cheminformatics  
The development of software and tools for computer  assisted organic synthesis are under vast 
development. This has resulted in many tools and representations for chemical structures. Some of 
the tools are listed below [3][13][15][21]. 
 ISIS-Draw is a chemical structure drawing program for Windows, published by MDL 
Information Systems. It is the interfacial software to ISIS/Base database [20].  
 ChemDraw is a molecu le editor developed by the cheminformat ics company 
CambridgeSoft. ChemDraw is, along with Chem3D and ChemFinder, part o f the 
ChemOffice suite of programs and is  available for Macintosh and Microsoft Windows [20]. 
 ChemWindow, is a chemical structure drawing program with several template. The 
template can be created by the customer can be saved in template folder and opened in 
preference dialogue box [20]. 
 ChemSketch, is a chemical structure drawing program with predefined templates are 
available for drawing and it  is more powerful and user friendly tool fo r structure analysis 
[20]. 
 ChemReader is a software developer toolkit for translating dig ital raster images of chemical 
structures into standard, chemical file formats that can be searched and analyzed with other 
open source or commercial cheminformatic software [36]. 
  JME Molecu lar Editor is a Java applet which allows to draw / edit  molecules and react ions 
(including generation of substructure queries) and to depict molecules directly within an 
HTML page [37]. 
 LogCHEM, an Inductive Logic Programming (ILP) based tool for discriminative 
interactive mining of chemical fragments [22]. 
 PLSR (PLS-Regression), a simple chemmetrics tool, which relates two matrix X and Y 
through linear multivariate model and has the ability to analyse data with many, noisy, 
collinear, and even incomplete variables in both X and Y [25].  
 Wendi (Web Engine for Nonobvious Drug Information), a web based integrative data 
mining tool. It attempts to find non-obvious relationships between a query compound and 
scholarly  publications, bio logical properties, genes and diseases using multiple informat ion 
sources [26].  
  ChemMine tool is an  online service for small molecule analysis. It  provides an interface 
between cheminformat ics and data mining tools for various analytical analyses in chemical 
genomics and drug discovery [27].  
 CML (Chemical Markup Language) is degined as combination of semantic text and non-
textual information of chemical strucutre on the internet. It acts like HTML pages [39][40]. 
 MyChemise (My Chemical Structure Editor) is a new 2D structure editor. It is designed as 
a Java applet that enables the direct creation of structures in the Internet using a web 
browser. MyChemise saves files in  a dig ital format (.cse) and the import and export of .mol 
files using the appropriate connection tables is also possible [41]. 
   PubChem is an open repository for small molecules and their experimenta l b iological 
activity. It integrates and provides search, retrieval, visualization, analysis, and 
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programmat ic access tools in an effort to maximize the utility of contributed information 
[43]. 
 Open Babel is a chemical tool box which interconverts chemical structures between 
different formats, over 110 formats [42]. 
 AmberTools is used Biomolecu lar simulation and analysis of polymers, nucleotides, and 
synthetic organic structures [44].  
Some other tools such as, CAS Draw, DIVA (Diverse Information, Visualization and Analysis), 
Structure Checker Accord, DS Accord Chemistry Cart ridge, Marv inSketch PowerMV, TINKER, APBS, 
ArgusLab, Babel, ioSolveIT, ChemTK, Chimera, CLIFF, Dragon, gOpenMol, Grace, JOELib, Jmol, 
IA_LOGP, Lammps, MIPSIM, Mol2Mol, AMSOL, MOLCAS, Molexel, ICM-Pro, ORTEP, Packmol, 
Polar, XLOGP,PREMIER Biosoft, Q-chem, ALOGPS, Qmol, SageMD, ChemTK Lite, Transient, 
CLOGP,TURBOMOLE, UNIVIS, VMD, WHATIF, GCluto, COSMOlogic, KOWWIN are also used for 
similar kind of applications mentioned above. 
4. Role of Cheminformatics in Morden Drug Discovery 
Recent chemical developments for drug discovery are generating a lot of chemical data which is 
referred as information  exp losion. This has created a demand to effectively  collect, organize, analyse and 
apply the chemical information in the process of modern d rug discovery and development [24]. The drug 
discovery process is aimed  at discovering molecules that can be very rapid ly developed for effect ive 
treatments to meet medical needs. 
The entanglement of chemistry and information management started in the mid  of 1970s, applying 
in the area of predict ion of protein structure, Fourier transform of X-ray crystallography, enzyme and 
chemical kinetics, analyse various types of spectroscopy data and binding of chemical compoun ds. 
During early 1980s, computer technology is considered as the core component by the medical chemist to 
solve chemical problems [4][10]. For example, co llect ing crystal structures of small molecules in 
Cambridge Structural Database (CSD) provides a fertile resource for geometrical data on molecular 
fragments for calibrat ion of force fields and validation of results from computational chemistry. The need 
of storing macromolecu lar data results in Protein  Data Base (PDB). The needs and refinement on these 
approaches result in several tools and upgrading the process of solving the problems. 
The traditional drug d iscovery process starts with a particu lar Disease, Identification of target, 
Identificat ion of molecule effective against target and Preclin ical testing. Identification of target and 
synthesis the molecule to increase their suitability takes more amounts of time and cost (in millions) 
discovery process of the drug. The development process starts with human clinical trials, approval from 
authority and delivers the product in the market. Th is process takes about 10-15 years to discover, 
develop and bring drug to the market [3][12]. 
 
   The modern pharmaceutical drug discovery and development pipeline process, as shown in Fig. 7, starts 
with Disease selection, Target identificat ion, Lead identification, Lead Optimization, Pre -clinical trial 
testing, Clinical trial testing, Approval and circulation (Drug in market). In trad itional drug discovery 
phase, the process which cost more time and money is replaced with lead identificat ion and lead 
optimization process in modern drug discovery system. Each phase has an interaction component that 
transfers data, knowledge and information to one another (shown in Fig. 8). 
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Fig. 7. Modern Drug Discovery and Development Life Cycle 
 
 
 
 
 
 
 
 
 
 
Fig. 8. Interaction Process 
 
4.1 Pre Drug Discovery Process (Disease identification) 
Before the discovery process starts, it is to understand the disease by knowing,  how the genes 
can be altered, how it affects the protein, how these protein will react with each other in living organis m, 
how the affected cells can change the specific tissues and how the disease affects the patient. All the 
phases in Pre-Discovery, Discovery and Development of Drug is shown in Fig. 9. 
 
Fig. 9. Drug Discovery and Development Process 
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4.2 Morden Drug Discovery Process 
The discovery process includes four important processes such as, target identificat ion and 
validation, lead identification, lead optimization and pre-clinical trials. 
a) Target Identification & Validation 
Cheminformat ics is used to identify target molecule which can be either gene or protein and 
could be a potential d rug for the disease (Gene/Protein analysis). The Identified  protein is separated, 
crystallized and ligand binding processes are done. Some approaches will inhib it the disease functionality 
by making the key  molecu le stop functioning. Another approach is by promoting specific molecule in the 
normal way which may have affected in the disease state. These approaches and different databases can 
be applied fo r the discovery of drug targets.  After target Identification, validation phase starts by 
determining whether the modulation of the target will y ield a desired clin ical outcome. This is base d on 
the results obtained between the cellu lar location and d isease/health condition, potential expression and 
protein binding state [30-32]. 
b) Lead Identification. 
Target -to-
Screening (HTS) technique is applied where the protein targets are automatically screened against 
database of small-molecule o r cell-based assay compounds. Lead  identificat ion also helps to see which 
molecules bind strongly to the target [35]. Several similarity and diversity techniques can be applied for 
lead identification [33-34]. 
c) Lead Optimization 
 This phase results in finding the drug candidate from the lead identified compound. The goal is a 
process of refin ing the chemical structure of a confirmed h it to improve its drug characteristics. Several 
docking techniques can be applied to optimize the lead structures for target affinity and selectivity [30-
32]. 
Different techniques and methods are used for Lead identification and Optimization process 
where some of the methods Virtual Screening, Molecular Database, Data mining, High -Throughput 
Screening (HTS), QSAR, Protein  Ligand Models, Structure Based Models, Microarray analysis,  
Property Calcu lation and ADMET(adsorption, distribution, metabolis m and elimination and Toxicity) 
[9][10][12]. 
d) Pre- Clinical Trial 
 The preclin ical stage is an important phase to check whether the compound can be made into a 
drug to treat specific d isease which is not toxic and has minimum side effects. Toxicity tests are 
undertaken to show safety while pharmacokinetics testing is done to provide data on how a drug is 
absorbed, distributed, metabolised and excreted (ADME) from the body. Pre-clin ical studies and testing 
can be done with or without animal testing method. In-vitro is a study, based on the test done in the 
clin ical lab and the analysis based on living cell cultures and an imal model can  be referred as in -viv io 
method. This phase will be designed in a way such that it achieves risk-free, unproblematic and economic 
transition from pre-clinical to clinical trial in medical product development [15][30-32]. 
4.3 Development Process 
Development process is another significant stage in the life cycle of finding new drug. This stag e 
consists of three major phase such as clinical trial, approval from the authority and drug in market.  
i) Clinical Trial 
Clin ical trial is the primary phase which will be fastest and safest way to find treatments which 
acts as the best solution for challenging health disease of human being. Patient with specific disease will 
be considered for clin ical trial and relevant data will be co llected with respect to the time. Trials can be 
done in five ways such as, prevention trials, screening trails, diagnostic tra ils, treatment trial and quality 
of life trials [15][30][31]. 
ii) Approval from the Authority and Drug in Market 
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 Based on the rules and regulation for new drug development in the country as well as in 
international market, research authorities check the safety and other parameters to approve the drug for 
market ing. Central Drugs Standard Control Organizat ion (CDSCO) in India and Food and Drug 
Admin istration (FDA) in U.K. approves a new pharmaceutical compound for sales and marketing  [9-
13][15]. 
5. Conclusion 
 Average life span of Human being is gradually  decreasing in the recent medical history due to 
the higher influence of new d iseases. Identifying and understanding structural and functional behaviour of 
chemical compounds/biomolecules are one of the challenging issues for medical researchers. 
Cheminformat ics is an emerging field which  is used for better understanding of biomolecules. Th is paper 
primarily focuses on cheminformatics and its applications on drug discovery, issues of traditional 
discovery and importance of modern drug discovery system. This in turn helps chemists and researchers 
for developing drugs without side effects.   
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